Literature DB >> 30827370

Does the Flow Know? Mitral Regurgitant Jet Direction and Need for Valve Repair in Hypertrophic Obstructive Cardiomyopathy.

Ehud Schwammenthal1, Albert A Hagège2, Robert A Levine3.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30827370      PMCID： PMC7869849          DOI： 10.1016/j.echo.2019.01.005

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN： 0894-7317            Impact factor:   5.251


× No keyword cloud information.
  32 in total

1.  Intrinsic mitral valve alterations in hypertrophic cardiomyopathy sarcomere mutation carriers.

Authors:  John D Groarke; Patrycja Z Galazka; Allison L Cirino; Neal K Lakdawala; Jens J Thune; Henning Bundgaard; E John Orav; Robert A Levine; Carolyn Y Ho
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2018-10-01       Impact factor: 6.875

2.  Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy.

Authors:  Martin S Maron; Iacopo Olivotto; Caitlin Harrigan; Evan Appelbaum; C Michael Gibson; John R Lesser; Tammy S Haas; James E Udelson; Warren J Manning; Barry J Maron
Journal:  Circulation       Date:  2011-06-13       Impact factor: 29.690

3.  Familial hypertrophic cardiomyopathy. Cardiac ultrasonic abnormalities in genetically affected subjects without echocardiographic evidence of left ventricular hypertrophy.

Authors:  A A Hagège; O Dubourg; M Desnos; R Mirochnik; G Isnard; G Bonne; L Carrier; P Guicheney; J B Bouhour; K Schwartz; M Komajda
Journal:  Eur Heart J       Date:  1998-03       Impact factor: 29.983

4.  An integrated mechanism for systolic anterior motion of the mitral valve in hypertrophic cardiomyopathy based on echocardiographic observations.

Authors:  L Jiang; R A Levine; M E King; A E Weyman
Journal:  Am Heart J       Date:  1987-03       Impact factor: 4.749

5.  Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β.

Authors:  Polakit Teekakirikul; Seda Eminaga; Okan Toka; Ronny Alcalai; Libin Wang; Hiroko Wakimoto; Matthew Nayor; Tetsuo Konno; Joshua M Gorham; Cordula M Wolf; Jae B Kim; Joachim P Schmitt; Jefferey D Molkentin; Russell A Norris; Andrew M Tager; Stanley R Hoffman; Roger R Markwald; Christine E Seidman; Jonathan G Seidman
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

6.  Transesophageal Doppler echocardiography in obstructive hypertrophic cardiomyopathy: clarification of pathophysiology and importance in intraoperative decision making.

Authors:  L E Grigg; E D Wigle; W G Williams; L B Daniel; H Rakowski
Journal:  J Am Coll Cardiol       Date:  1992-07       Impact factor: 24.094

7.  Sustained improvement after combined anterior mitral leaflet extension and myectomy in hypertrophic obstructive cardiomyopathy.

Authors:  Chris van der Lee; Marcel J M Kofflard; Lex A van Herwerden; Willem B Vletter; Folkert J ten Cate
Journal:  Circulation       Date:  2003-09-29       Impact factor: 29.690

8.  Symptomatic exercise-induced left ventricular outflow tract obstruction without left ventricular hypertrophy.

Authors:  Eyad K Alhaj; Bette Kim; Deborah Cantales; Seth Uretsky; Farooq A Chaudhry; Mark V Sherrid
Journal:  J Am Soc Echocardiogr       Date:  2013-03-25       Impact factor: 5.251

9.  Mitral valve abnormalities in hypertrophic cardiomyopathy: echocardiographic features and surgical outcomes.

Authors:  Ryan K Kaple; Ross T Murphy; Linda M DiPaola; Penny L Houghtaling; Harry M Lever; Bruce W Lytle; Eugene H Blackstone; Nicholas G Smedira
Journal:  Ann Thorac Surg       Date:  2008-05       Impact factor: 4.330

10.  Targeted Mybpc3 Knock-Out Mice with Cardiac Hypertrophy Exhibit Structural Mitral Valve Abnormalities.

Authors:  Daniel P Judge; Hany Neamatalla; Russell A Norris; Robert A Levine; Jonathan T Butcher; Nicolas Vignier; Kevin H Kang; Quangtung Nguyen; Patrick Bruneval; Marie-Cécile Perier; Emmanuel Messas; Xavier Jeunemaitre; Annemarieke de Vlaming; Roger Markwald; Lucie Carrier; Albert A Hagège
Journal:  J Cardiovasc Dev Dis       Date:  2015-04-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.